Cancer survivor closing in on ARC comeback

Troy Dowel is on the road to recovery from a second bout of leukaemia. Image: DMAC Photography
Dowel had already beaten leukaemia once but relapsed at the start of this year.
Instead of traditional chemotherapy, though, he has been put on a trial drug called Blinatumomab this time around.
After five weeks, Dowel’s residual disease count is now at zero per cent at the completion of the first cycle of treatment.
Not only has that initial cycle proved a success at eliminating the disease, the